SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4qny'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GX8_A_RTLA1163_0
(BETA-LACTOGLOBULIN)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 9 LEU A 310
GLU A 123
ILE A 130
VAL A 208
MET A 290
 None
 1.48A 1gx8A-4qnyA:
undetectable		 1gx8A-4qnyA:
21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TW4_A_CHDA130_1
(FATTY ACID-BINDING
PROTEIN)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		3 / 3 TYR A 190
ARG A 116
GLN A 113
 None
None
ANP  A 402 ( 4.2A)
 0.89A 1tw4A-4qnyA:
undetectable		 1tw4A-4qnyA:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWJ_A_BAXA1723_2
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 7 ILE A  27
LEU A  74
ILE A  82
ASP A 167
 ANP  A 402 (-4.6A)
None
None
ANP  A 402 ( 2.6A)
 0.84A 1uwjA-4qnyA:
22.2		 1uwjA-4qnyA:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWJ_A_BAXA1723_2
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 7 ILE A  27
LYS A  51
LEU A  74
ILE A  82
 ANP  A 402 (-4.6A)
ANP  A 402 (-2.8A)
None
None
 0.72A 1uwjA-4qnyA:
22.2		 1uwjA-4qnyA:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VE3_A_SAMA302_1
(HYPOTHETICAL PROTEIN
PH0226)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 4 TYR A  21
ARG A  20
ASP A 105
ASP A  80
 None
 1.35A 1ve3A-4qnyA:
undetectable		 1ve3A-4qnyA:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VE3_B_SAMB301_1
(HYPOTHETICAL PROTEIN
PH0226)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 4 TYR A  21
ARG A  20
ASP A 105
ASP A  80
 None
 1.37A 1ve3B-4qnyA:
2.6		 1ve3B-4qnyA:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_A_B49A1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 12 ILE A  27
VAL A  35
ALA A  49
ILE A  83
MET A 107
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.8A)
None
ANP  A 402 (-4.6A)
 0.38A 2y7jA-4qnyA:
28.1		 2y7jA-4qnyA:
23.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_B_B49B1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 10 ILE A  27
VAL A  35
ALA A  49
ILE A  83
MET A 107
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.8A)
None
ANP  A 402 (-4.6A)
 0.37A 2y7jB-4qnyA:
28.2		 2y7jB-4qnyA:
23.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_C_B49C1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 10 ILE A  27
VAL A  35
ALA A  49
ILE A  83
MET A 107
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.8A)
None
ANP  A 402 (-4.6A)
 0.37A 2y7jC-4qnyA:
28.2		 2y7jC-4qnyA:
23.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_D_B49D1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 10 ILE A  27
VAL A  35
ALA A  49
ILE A  83
MET A 107
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.8A)
None
ANP  A 402 (-4.6A)
 0.36A 2y7jD-4qnyA:
28.2		 2y7jD-4qnyA:
23.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GCS_A_BAXA401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 12 ALA A  49
LEU A  74
ILE A  83
ILE A 140
HIS A 147
 ANP  A 402 (-3.3A)
None
ANP  A 402 (-4.8A)
None
None
 1.03A 3gcsA-4qnyA:
32.4		 3gcsA-4qnyA:
38.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GP0_A_NILA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 11)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 12 VAL A  35
ALA A  49
GLU A  70
LEU A  73
LEU A  74
ILE A  83
 ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-3.0A)
None
None
ANP  A 402 (-4.8A)
 0.52A 3gp0A-4qnyA:
35.8		 3gp0A-4qnyA:
37.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GP0_A_NILA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 11)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		7 / 12 VAL A  35
ALA A  49
LEU A  73
LEU A  74
ILE A  83
HIS A 147
ASP A 167
 ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
None
None
ANP  A 402 (-4.8A)
None
ANP  A 402 ( 2.6A)
 0.96A 3gp0A-4qnyA:
35.8		 3gp0A-4qnyA:
37.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3HEC_A_STIA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 12 ALA A  49
LYS A  51
GLU A  70
LEU A  73
LEU A  74
 ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
ANP  A 402 (-3.0A)
None
None
 0.66A 3hecA-4qnyA:
32.8		 3hecA-4qnyA:
38.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3HEC_A_STIA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 12 ALA A  49
LYS A  51
GLU A  70
LEU A  74
ILE A  83
 ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
ANP  A 402 (-3.0A)
None
ANP  A 402 (-4.8A)
 0.57A 3hecA-4qnyA:
32.8		 3hecA-4qnyA:
38.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3HEG_A_BAXA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 12 VAL A  35
ALA A  49
LYS A  51
LEU A  74
ILE A  83
ILE A 140
 ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
None
ANP  A 402 (-4.8A)
None
 1.14A 3hegA-4qnyA:
33.5		 3hegA-4qnyA:
38.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_K_TFPK201_1
(PROTEIN S100-A4)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 8 GLY A  84
ILE A 139
PHE A 328
PHE A 168
 None
 1.05A 3ko0K-4qnyA:
undetectable
3ko0S-4qnyA:
undetectable		 3ko0K-4qnyA:
14.04
3ko0S-4qnyA:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LB3_B_4CHB192_0
(DEHALOPEROXIDASE A)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 6 PHE A  58
PHE A  97
HIS A  99
VAL A  53
 None
 1.14A 3lb3B-4qnyA:
1.2		 3lb3B-4qnyA:
16.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MIY_B_B49B2_1
(TYROSINE-PROTEIN
KINASE ITK/TSK)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 9 ILE A  27
ALA A  49
LYS A  51
MET A 107
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
None
ANP  A 402 (-4.6A)
 0.72A 3miyB-4qnyA:
22.2		 3miyB-4qnyA:
24.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OEZ_A_STIA601_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 5 LYS A  51
ILE A 102
MET A 107
ARG A 148
 ANP  A 402 (-2.8A)
None
None
None
 0.99A 3oezA-4qnyA:
21.3		 3oezA-4qnyA:
27.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OHT_B_1N1B1000_1
(P38A)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 12 VAL A  35
ALA A  49
LYS A  51
LEU A  74
ILE A  83
 ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
None
ANP  A 402 (-4.8A)
 0.47A 3ohtB-4qnyA:
9.0		 3ohtB-4qnyA:
38.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V5W_A_8PRA701_1
(G-PROTEIN COUPLED
RECEPTOR KINASE 2)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		7 / 12 ILE A  27
GLY A  30
GLY A  33
VAL A  35
ALA A  49
LYS A  51
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 (-3.4A)
None
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
ANP  A 402 (-4.6A)
 0.92A 3v5wA-4qnyA:
7.9		 3v5wA-4qnyA:
19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZE_A_BAXA1201_2
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 8 LEU A 156
ILE A 165
CYH A 166
ASP A 167
 ANP  A 402 (-4.6A)
None
ANP  A 402 ( 4.3A)
ANP  A 402 ( 2.6A)
 0.71A 3wzeA-4qnyA:
21.8		 3wzeA-4qnyA:
28.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ANS_A_VGHA9000_1
(ALK TYROSINE KINASE
RECEPTOR)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 9 VAL A  35
ALA A  49
MET A 104
MET A 107
LEU A 156
ASP A 167
 ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.4A)
None
ANP  A 402 (-4.6A)
ANP  A 402 ( 2.6A)
 0.60A 4ansA-4qnyA:
22.4		 4ansA-4qnyA:
25.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		8 / 12 ALA A  49
LYS A  51
GLU A  70
LEU A  74
ILE A 102
HIS A 147
LEU A 156
ASP A 167
 ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
ANP  A 402 (-3.0A)
None
None
None
ANP  A 402 (-4.6A)
ANP  A 402 ( 2.6A)
 0.96A 4c8bA-4qnyA:
22.0		 4c8bA-4qnyA:
24.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_2
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 5 VAL A  35
ILE A  82
MET A 107
ILE A 165
 ANP  A 402 (-4.3A)
None
None
None
 0.45A 4c8bA-4qnyA:
22.0		 4c8bA-4qnyA:
24.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_2
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 5 VAL A  35
ILE A 165
MET A 107
ILE A 155
 ANP  A 402 (-4.3A)
None
None
None
 0.92A 4c8bA-4qnyA:
22.0		 4c8bA-4qnyA:
24.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EXS_B_X8ZB301_1
(BETA-LACTAMASE NDM-1)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 8 VAL A 301
HIS A 147
ASP A 207
HIS A 141
 None
 0.87A 4exsB-4qnyA:
undetectable		 4exsB-4qnyA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FP9_C_SAMC401_1
(METHYLTRANSFERASE
NSUN4)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		3 / 3 ASP A 105
ARG A  86
ASP A  80
 None
 0.83A 4fp9C-4qnyA:
undetectable		 4fp9C-4qnyA:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FP9_F_SAMF401_1
(METHYLTRANSFERASE
NSUN4)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		3 / 3 ASP A 105
ARG A  86
ASP A  80
 None
 0.84A 4fp9F-4qnyA:
undetectable		 4fp9F-4qnyA:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I41_A_MIXA500_1
(SERINE/THREONINE-PRO
TEIN KINASE PIM-1)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		8 / 12 VAL A  35
ALA A  49
ILE A  83
ASP A 110
ASP A 149
ASN A 154
LEU A 156
ASP A 167
 ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.8A)
ANP  A 402 (-3.4A)
None
MG  A 401 ( 2.7A)
ANP  A 402 (-4.6A)
ANP  A 402 ( 2.6A)
 0.76A 4i41A-4qnyA:
24.6		 4i41A-4qnyA:
27.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J24_B_ESTB600_1
(ESTROGEN RECEPTOR
BETA)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 12 LEU A 219
LEU A 291
MET A 290
ILE A 126
ILE A 130
 None
 1.07A 4j24B-4qnyA:
undetectable		 4j24B-4qnyA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KIC_B_SAMB401_1
(METHYLTRANSFERASE
MPPJ)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		3 / 3 ARG A 148
ASP A 167
ASP A 110
 None
ANP  A 402 ( 2.6A)
ANP  A 402 (-3.4A)
 0.59A 4kicB-4qnyA:
undetectable		 4kicB-4qnyA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NDN_C_SAMC405_1
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 8 ALA A 136
ASP A 110
ILE A 155
ILE A 214
 None
ANP  A 402 (-3.4A)
None
None
 0.96A 4ndnD-4qnyA:
undetectable		 4ndnD-4qnyA:
21.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OGR_A_ADNA401_1
(CYCLIN-DEPENDENT
KINASE 9)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 8 ILE A  27
VAL A  35
ALA A  49
ASP A 110
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-3.4A)
ANP  A 402 (-4.6A)
 0.61A 4ogrA-4qnyA:
31.7		 4ogrA-4qnyA:
32.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OGR_A_ADNA401_1
(CYCLIN-DEPENDENT
KINASE 9)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 8 VAL A  35
ALA A  49
ASP A 110
ASN A 154
LEU A 156
 ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-3.4A)
MG  A 401 ( 2.7A)
ANP  A 402 (-4.6A)
 0.60A 4ogrA-4qnyA:
31.7		 4ogrA-4qnyA:
32.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OGR_E_ADNE401_1
(CYCLIN-DEPENDENT
KINASE 9)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 7 ALA A  49
ASP A 110
ASN A 154
LEU A 156
ASP A 167
 ANP  A 402 (-3.3A)
ANP  A 402 (-3.4A)
MG  A 401 ( 2.7A)
ANP  A 402 (-4.6A)
ANP  A 402 ( 2.6A)
 0.74A 4ogrE-4qnyA:
30.9		 4ogrE-4qnyA:
32.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OGR_I_ADNI401_1
(CYCLIN-DEPENDENT
KINASE 9)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 9 ILE A  27
VAL A  35
ALA A  49
ASP A 110
ASN A 154
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-3.4A)
MG  A 401 ( 2.7A)
ANP  A 402 (-4.6A)
 0.73A 4ogrI-4qnyA:
31.6		 4ogrI-4qnyA:
32.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OU1_A_BEZA302_0
(RETRO-ALDOLASE,
DESIGN RA114)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 8 ILE A 155
ILE A 165
ASN A  81
ALA A 136
 None
 0.87A 4ou1A-4qnyA:
undetectable		 4ou1A-4qnyA:
24.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMN_A_DB8A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 12 ILE A  27
ALA A  49
GLU A  70
ILE A 102
LEU A 156
ASP A 167
 ANP  A 402 (-4.6A)
ANP  A 402 (-3.3A)
ANP  A 402 (-3.0A)
None
ANP  A 402 (-4.6A)
ANP  A 402 ( 2.6A)
 0.69A 4qmnA-4qnyA:
25.9		 4qmnA-4qnyA:
25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMN_A_DB8A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 12 ILE A  27
ALA A  49
LYS A  51
GLU A  70
ILE A 102
ASP A 167
 ANP  A 402 (-4.6A)
ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
ANP  A 402 (-3.0A)
None
ANP  A 402 ( 2.6A)
 0.74A 4qmnA-4qnyA:
25.9		 4qmnA-4qnyA:
25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMS_A_1N1A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		7 / 11 ILE A  27
ALA A  49
LYS A  51
GLU A  70
ILE A 102
LEU A 156
ASP A 167
 ANP  A 402 (-4.6A)
ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
ANP  A 402 (-3.0A)
None
ANP  A 402 (-4.6A)
ANP  A 402 ( 2.6A)
 0.82A 4qmsA-4qnyA:
25.8		 4qmsA-4qnyA:
25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMZ_A_B49A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 12 ILE A  27
GLY A  28
VAL A  35
ALA A  49
MET A 104
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 ( 3.7A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.4A)
ANP  A 402 (-4.6A)
 0.68A 4qmzA-4qnyA:
26.1		 4qmzA-4qnyA:
25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RET_A_DGXA1107_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 12 GLN A 205
LEU A 137
GLY A 210
LEU A 286
ARG A 288
 None
 1.29A 4retA-4qnyA:
undetectable		 4retA-4qnyA:
17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RET_C_DGXC2005_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 12 GLN A 205
LEU A 137
GLY A 210
LEU A 286
ARG A 288
 None
 1.29A 4retC-4qnyA:
undetectable		 4retC-4qnyA:
17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4U0I_A_0LIA1001_2
(MAST/STEM CELL
GROWTH FACTOR
RECEPTOR
KIT,MAST/STEM CELL
GROWTH FACTOR
RECEPTOR KIT)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		7 / 12 ALA A  49
LYS A  51
LEU A  74
HIS A 147
LEU A 156
CYH A 166
ASP A 167
 ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
None
None
ANP  A 402 (-4.6A)
ANP  A 402 ( 4.3A)
ANP  A 402 ( 2.6A)
 0.80A 4u0iA-4qnyA:
21.6		 4u0iA-4qnyA:
26.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V01_B_0LIB1770_2
(FIBROBLAST GROWTH
FACTOR RECEPTOR 1
(FMS-RELATED
TYROSINE KINASE 2,
PFEIFFER SYNDROME),
ISOFORM CRA_B)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 9 VAL A  35
LYS A  51
ILE A  83
ARG A 148
LEU A 156
ILE A 165
 ANP  A 402 (-4.3A)
ANP  A 402 (-2.8A)
ANP  A 402 (-4.8A)
None
ANP  A 402 (-4.6A)
None
 0.87A 4v01B-4qnyA:
22.0		 4v01B-4qnyA:
26.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WBO_C_ANWC601_0
(RHODOPSIN KINASE)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 6 ALA A  49
MET A 104
MET A 107
LEU A 156
 ANP  A 402 (-3.3A)
ANP  A 402 (-4.4A)
None
ANP  A 402 (-4.6A)
 0.61A 4wboC-4qnyA:
26.6		 4wboC-4qnyA:
18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A1R_A_STRA600_1
(CYTOCHROME P450 3A4)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 5 PHE A 100
ASP A  98
PHE A  58
VAL A  53
 None
 1.21A 5a1rA-4qnyA:
undetectable		 5a1rA-4qnyA:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 8 VAL A 301
HIS A 147
ASP A 207
HIS A 141
 None
 0.83A 5a5zA-4qnyA:
undetectable		 5a5zA-4qnyA:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HES_A_032A401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE MLT)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 12 VAL A  35
ALA A  49
ILE A  83
ILE A 102
CYH A 166
 ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.8A)
None
ANP  A 402 ( 4.3A)
 0.54A 5hesA-4qnyA:
6.1		 5hesA-4qnyA:
26.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IH0_A_ERYA404_1
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E II)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 6 TYR A 101
ASP A  98
HIS A  99
ILE A  57
 None
 1.17A 5ih0A-4qnyA:
5.0		 5ih0A-4qnyA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IK1_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 5 LEU A  73
GLY A 169
ASP A 207
ILE A 150
 None
ANP  A 402 ( 3.8A)
None
None
 0.90A 5ik1A-4qnyA:
undetectable		 5ik1A-4qnyA:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IZJ_F_AZ1F2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAR-DAR-DAR)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 7 GLY A  28
GLY A  30
SER A  31
GLY A  33
 ANP  A 402 ( 3.7A)
ANP  A 402 (-3.4A)
None
None
 0.21A 5izjB-4qnyA:
25.7		 5izjB-4qnyA:
25.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IZJ_G_AZ1G2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAR-DAR)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 7 GLY A  28
GLY A  30
SER A  31
LYS A  51
 ANP  A 402 ( 3.7A)
ANP  A 402 (-3.4A)
None
ANP  A 402 (-2.8A)
 0.45A 5izjA-4qnyA:
26.3		 5izjA-4qnyA:
25.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_B_ADNB401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 9 ILE A  27
GLY A  28
VAL A  35
ALA A  49
ILE A  83
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 ( 3.7A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.8A)
ANP  A 402 (-4.6A)
 1.43A 5lw1B-4qnyA:
35.2		 5lw1B-4qnyA:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_B_ADNB401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		7 / 9 ILE A  27
GLY A  28
VAL A  35
ALA A  49
ILE A  83
MET A 104
MET A 107
 ANP  A 402 (-4.6A)
ANP  A 402 ( 3.7A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.8A)
ANP  A 402 (-4.4A)
None
 0.46A 5lw1B-4qnyA:
35.2		 5lw1B-4qnyA:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_E_ADNE401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 10 GLY A  28
VAL A  35
ALA A  49
ILE A  83
MET A 104
LEU A 156
 ANP  A 402 ( 3.7A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.8A)
ANP  A 402 (-4.4A)
ANP  A 402 (-4.6A)
 1.37A 5lw1E-4qnyA:
34.9		 5lw1E-4qnyA:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_E_ADNE401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		6 / 10 GLY A  28
VAL A  35
ALA A  49
ILE A  83
MET A 104
MET A 107
 ANP  A 402 ( 3.7A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.8A)
ANP  A 402 (-4.4A)
None
 0.50A 5lw1E-4qnyA:
34.9		 5lw1E-4qnyA:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_H_ADNH401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 9 GLY A  28
VAL A  35
ALA A  49
MET A 104
MET A 107
 ANP  A 402 ( 3.7A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-4.4A)
None
 0.48A 5lw1H-4qnyA:
35.3		 5lw1H-4qnyA:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OWR_A_1N1A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		4 / 8 ALA A  49
GLU A  70
LEU A 156
ASP A 167
 ANP  A 402 (-3.3A)
ANP  A 402 (-3.0A)
ANP  A 402 (-4.6A)
ANP  A 402 ( 2.6A)
 0.69A 5owrA-4qnyA:
21.4		 5owrA-4qnyA:
28.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VEU_H_RITH602_1
(CYTOCHROME P450 3A5)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		5 / 12 LEU A 156
GLY A  30
ILE A 106
GLU A  70
GLY A  33
 ANP  A 402 (-4.6A)
ANP  A 402 (-3.4A)
ANP  A 402 (-4.6A)
ANP  A 402 (-3.0A)
None
 0.96A 5veuH-4qnyA:
undetectable		 5veuH-4qnyA:
22.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BSD_A_1N1A901_0
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		7 / 12 VAL A  35
ALA A  49
LYS A  51
GLU A  70
ILE A  83
MET A 107
LEU A 156
 ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
ANP  A 402 (-3.0A)
ANP  A 402 (-4.8A)
None
ANP  A 402 (-4.6A)
 0.64A 6bsdA-4qnyA:
20.9		 6bsdA-4qnyA:
11.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FNM_A_1N1A1001_1
(-)		 4qny MITOGEN ACTIVATED
PROTEIN KINASE,
PUTATIVE
(Leishmania
donovani) 		7 / 12 ILE A  27
VAL A  35
ALA A  49
LYS A  51
ILE A 102
MET A 107
LEU A 156
 ANP  A 402 (-4.6A)
ANP  A 402 (-4.3A)
ANP  A 402 (-3.3A)
ANP  A 402 (-2.8A)
None
None
ANP  A 402 (-4.6A)
 0.73A 6fnmA-4qnyA:
23.0		 6fnmA-4qnyA:
28.23